Circulating level of FABP4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.
Marenao TanakaSatoko TakahashiYukimura HigashiuraAkiko SakaiMasayuki KoyamaShigeyuki SaitohKazuaki ShimamotoHirofumi OhnishiMasato FuruhashiPublished in: Journal of diabetes investigation (2021)
FABP4 concentration is independently associated with FLI and is an independent predictor of MAFLD in middle-aged and elderly individuals.